FI954883A0 - Manufacture of matrices - Google Patents
Manufacture of matricesInfo
- Publication number
- FI954883A0 FI954883A0 FI954883A FI954883A FI954883A0 FI 954883 A0 FI954883 A0 FI 954883A0 FI 954883 A FI954883 A FI 954883A FI 954883 A FI954883 A FI 954883A FI 954883 A0 FI954883 A0 FI 954883A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- cellulose
- matrices
- date oct
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/05—Elimination by evaporation or heat degradation of a liquid phase
- C08J2201/0504—Elimination by evaporation or heat degradation of a liquid phase the liquid phase being aqueous
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/02—Cellulose; Modified cellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Inorganic Insulating Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Polymerisation Methods In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Glass Compositions (AREA)
- Vending Machines For Individual Products (AREA)
Abstract
PCT No. PCT/SE94/00331 Sec. 371 Date Oct. 11, 1995 Sec. 102(e) Date Oct. 11, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/23703 PCT Pub. Date Oct. 27, 1994Porous cellulose matrices with a defined particle size and a significantly higher porosity (i.e. pore volume) than conventional formulations, such as pellet formulations containing cellulose and binders are prepared. The cellulose is mechanically treated with low adhesion to the process equipment during a controlled gradual addition of an aqueous based fluid, optionally containing a surface-active ingredient, into regular particles, which are finally dried to obtain dry porous cellulose matrices. The so obtained matrices can be used as carriers for bioactive substances in multiple-unit preparations or tablets.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9301220 | 1993-04-14 | ||
SE19939301220A SE9301220D0 (en) | 1993-04-14 | 1993-04-14 | MANUFACTURING MATRICES |
SE9400331 | 1994-02-02 | ||
PCT/SE1994/000331 WO1994023703A1 (en) | 1993-04-14 | 1994-04-14 | Manufacturing matrices |
Publications (3)
Publication Number | Publication Date |
---|---|
FI954883A0 true FI954883A0 (en) | 1995-10-13 |
FI954883A FI954883A (en) | 1995-10-13 |
FI115442B FI115442B (en) | 2005-05-13 |
Family
ID=20389559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954883A FI115442B (en) | 1993-04-14 | 1995-10-13 | Preparation of matrices |
Country Status (16)
Country | Link |
---|---|
US (1) | US5804217A (en) |
EP (1) | EP0695173B1 (en) |
JP (1) | JP3385369B2 (en) |
AT (1) | ATE189120T1 (en) |
AU (1) | AU680494B2 (en) |
CA (1) | CA2159908C (en) |
DE (1) | DE69422806T2 (en) |
DK (1) | DK0695173T3 (en) |
ES (1) | ES2144517T3 (en) |
FI (1) | FI115442B (en) |
GR (1) | GR3033274T3 (en) |
NO (1) | NO312085B1 (en) |
NZ (1) | NZ265131A (en) |
PT (1) | PT695173E (en) |
SE (1) | SE9301220D0 (en) |
WO (1) | WO1994023703A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ335737A (en) * | 1996-11-12 | 2000-09-29 | Pharmacia & Upjohn Ab | Compact member comprising a plurality of porous cellulose matrices (PCMs) |
US6599620B2 (en) | 1997-01-07 | 2003-07-29 | Kaneka Corporation | Cellulosic particles, spherical object comprising cross-linked polymer particles, and adsorbent for body fluid purification |
JP2002531491A (en) | 1998-12-11 | 2002-09-24 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | Sustained-release tablet containing hydrocolloid and cellulose ether |
US6572887B2 (en) * | 2000-05-01 | 2003-06-03 | National Starch And Chemical Investment Holding Corporation | Polysaccharide material for direct compression |
US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
US8153157B2 (en) | 2005-04-22 | 2012-04-10 | Asahi Kasei Chemicals Corporation | Porous cellulose aggregate and molding composition thereof |
WO2009142255A1 (en) * | 2008-05-21 | 2009-11-26 | 旭化成ケミカルズ株式会社 | Cellulose powder having excellent segregation preventive effect, and compositions thereof |
HUE050303T2 (en) * | 2013-03-13 | 2020-11-30 | Intervet Int Bv | Stable bioactive substances and methods of making |
JP6522396B2 (en) * | 2015-04-02 | 2019-05-29 | 北越コーポレーション株式会社 | Method for producing cellulose porous body |
AU2019101024A4 (en) * | 2018-12-24 | 2019-10-10 | Thomas W Railsback | Improved cooling apparatus |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL286829A (en) * | 1961-12-29 | |||
US3873694A (en) * | 1973-09-27 | 1975-03-25 | Cpc International Inc | Direct compression tabletting composition and pharmaceutical tablets produced therefrom |
CS172640B1 (en) * | 1974-05-30 | 1977-01-28 | ||
US4063017A (en) * | 1976-04-22 | 1977-12-13 | Purdue Research Foundation | Porous cellulose beads and the immobilization of enzymes therewith |
SE434848B (en) * | 1976-04-22 | 1984-08-20 | Purdue Research Foundation | METHOD OF PROCEDURE FOR POROSA CELLULOSAPERLOR |
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US4269859A (en) * | 1979-04-19 | 1981-05-26 | Brown Company | Cellulose floc granules and process |
DK150008C (en) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ORAL POLYDEPOT PREPARATION |
US4464224A (en) * | 1982-06-30 | 1984-08-07 | Cip Inc. | Process for manufacture of high bulk paper |
DK151608C (en) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | PROCEDURE FOR PREPARING A PHARMACEUTICAL PERORAL POLYDEPOT PREPARATION WITH CONTROLLED RELEASE |
US4775535A (en) * | 1986-04-04 | 1988-10-04 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
US4855143A (en) * | 1986-04-04 | 1989-08-08 | Hans Lowey | Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
GB8618811D0 (en) * | 1986-08-01 | 1986-09-10 | Approved Prescription Services | Sustained release ibuprofen formulation |
GB8628728D0 (en) * | 1986-12-02 | 1987-01-07 | Euro Celtique Sa | Spheroids |
US4808413A (en) * | 1987-04-28 | 1989-02-28 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions in the form of beadlets and method |
JPS6443530A (en) * | 1987-08-10 | 1989-02-15 | Asahi Chemical Ind | Porous cellulose particle and its production |
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
US4806360A (en) * | 1987-10-23 | 1989-02-21 | Advanced Polymer Systems | Synthetic melanin aggregates |
SE9002017D0 (en) * | 1990-06-06 | 1990-06-06 | Kabivitrum Ab | PROCESS FOR MANUFACTURE OF MATRICES |
DE69008526T2 (en) * | 1990-07-02 | 1994-08-18 | Bend Res Inc | Asymmetric microporous beads for adjustable release. |
DK0472502T3 (en) * | 1990-08-24 | 1995-10-09 | Spirig Ag | Process for producing pellets |
AU639137B2 (en) * | 1990-09-21 | 1993-07-15 | Merrell Dow Pharmaceuticals Inc. | Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
US5223090A (en) * | 1991-03-06 | 1993-06-29 | The United States Of America As Represented By The Secretary Of Agriculture | Method for fiber loading a chemical compound |
GB9117361D0 (en) * | 1991-08-12 | 1991-09-25 | Euro Celtique Sa | Oral dosage form |
KR100221695B1 (en) * | 1991-08-12 | 1999-09-15 | 그린 마틴, 브라이언 쥐 테슬리 | Pharmaceutical spheroid formulation |
-
1993
- 1993-04-14 SE SE19939301220A patent/SE9301220D0/en unknown
-
1994
- 1994-04-14 DK DK94913238T patent/DK0695173T3/en active
- 1994-04-14 PT PT94913238T patent/PT695173E/en unknown
- 1994-04-14 WO PCT/SE1994/000331 patent/WO1994023703A1/en active IP Right Grant
- 1994-04-14 US US08/532,716 patent/US5804217A/en not_active Expired - Fee Related
- 1994-04-14 AU AU65473/94A patent/AU680494B2/en not_active Ceased
- 1994-04-14 ES ES94913238T patent/ES2144517T3/en not_active Expired - Lifetime
- 1994-04-14 DE DE69422806T patent/DE69422806T2/en not_active Expired - Fee Related
- 1994-04-14 CA CA002159908A patent/CA2159908C/en not_active Expired - Fee Related
- 1994-04-14 JP JP52305194A patent/JP3385369B2/en not_active Expired - Fee Related
- 1994-04-14 NZ NZ265131A patent/NZ265131A/en unknown
- 1994-04-14 AT AT94913238T patent/ATE189120T1/en not_active IP Right Cessation
- 1994-04-14 EP EP94913238A patent/EP0695173B1/en not_active Expired - Lifetime
-
1995
- 1995-10-13 FI FI954883A patent/FI115442B/en not_active IP Right Cessation
- 1995-10-13 NO NO19954079A patent/NO312085B1/en unknown
-
2000
- 2000-04-19 GR GR20000400957T patent/GR3033274T3/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO954079D0 (en) | 1995-10-13 |
US5804217A (en) | 1998-09-08 |
JP3385369B2 (en) | 2003-03-10 |
EP0695173B1 (en) | 2000-01-26 |
NZ265131A (en) | 1998-05-27 |
CA2159908C (en) | 2003-12-30 |
DE69422806T2 (en) | 2000-08-17 |
GR3033274T3 (en) | 2000-09-29 |
NO312085B1 (en) | 2002-03-18 |
FI115442B (en) | 2005-05-13 |
JPH08510766A (en) | 1996-11-12 |
EP0695173A1 (en) | 1996-02-07 |
DK0695173T3 (en) | 2000-07-10 |
ATE189120T1 (en) | 2000-02-15 |
AU680494B2 (en) | 1997-07-31 |
WO1994023703A1 (en) | 1994-10-27 |
PT695173E (en) | 2000-07-31 |
CA2159908A1 (en) | 1994-10-27 |
DE69422806D1 (en) | 2000-03-02 |
SE9301220D0 (en) | 1993-04-14 |
NO954079L (en) | 1995-10-13 |
FI954883A (en) | 1995-10-13 |
AU6547394A (en) | 1994-11-08 |
ES2144517T3 (en) | 2000-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69230645D1 (en) | IMPLANT | |
DK0532611T3 (en) | Process for the preparation of porous cellulose matrices | |
ES8201316A1 (en) | Process for preparing lipoid-biologically active particles | |
FI954883A0 (en) | Manufacture of matrices | |
GB2186485B (en) | Slow release formulation | |
AU567968B2 (en) | Device for controlled release of active ingredients | |
CA2016297A1 (en) | Device and method for depletion of the leucocyte content of blood and blood components | |
SE8102292L (en) | PROCEDURE FOR PREPARING A MICROPOROS STRUCTURED SOLUBLE COFFEE PRODUCT | |
ES8707759A1 (en) | Antifoam ingredient for detergent compositions. | |
CA2205084A1 (en) | Implantable device for administering active substances to plants | |
JPS57204211A (en) | Membrane for purifying mineral oil | |
JPS5596095A (en) | Composite particle group containing active protein substance * production * use and regeneration thereof | |
NZ335737A (en) | Compact member comprising a plurality of porous cellulose matrices (PCMs) | |
EP0134081A3 (en) | Nutrients for mushroom culture | |
NZ331584A (en) | Air filtration means fitted into table to remove filtration matter/smoke | |
JPS5579011A (en) | Separation of oil emulsion | |
JPS57106610A (en) | Preparation of prolonged release type composite | |
Matje et al. | CONTRIBUTION TO THE CONDITIONING OF SIC-SINTER POWDER | |
JPS57186453A (en) | High-speed deodorizing method of raw garlic bulb | |
HUT56479A (en) | Process for producing compositions comprising plant protectives with controlled release of active ingredient and/or plant nourishing materials | |
JPS51111971A (en) | Air filter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 115442 Country of ref document: FI |
|
MA | Patent expired |